AllPennyStocks.com Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsche Bank lowered the boom on Thursday.

Other Penny Stock Movers

$500 Million AI Merger Sends This Microcap Soaring
Historic Gold Ground Gets a Fresh Drill Test
Washington Is Financing Critical-Mineral Projects. What Will Canada Do?
Most Popular
{{ index + 1 }}
AllPennyStocks.com Favorites


Back to Top